I reiterate my buy rating on Agnico Eagle Mines due to sharply higher EPS expectations and robust gold price momentum. AEM delivered stellar Q1 results, with strong gold production, disciplined cost control, and significant debt reduction, positioning it for further shareholder returns. Valuation is attractive: I raise my fair value target to $132, reflecting higher earnings estimates while remaining mindful of cyclical risks.
Meta Platforms (META) is reportedly planning to allow brands to use artificial intelligence to fully make and target ads by the end of next year.
Spanish Mountain Gold Ltd (TSX-V:SPA, OTC:SPAZF) said on Monday it has confirmed extensive near-surface gold mineralization at the Phoenix Target, part of its flagship Spanish Mountain Gold project in British Columbia. The company said drilling results define a mineralized zone around 1,450 metres long, 450 metres wide and up to 320 metres deep and open in all directions.
Conagra Brands is a defensive, high-quality packaged foods company with strong brands and a leading US frozen meals market share. Despite recent profit drops and supply chain issues, free cash flow remains robust, and the dividend yield is attractive at over 6%. The valuation is compelling, but I see risks from tariffs, debt, and potential dividend cuts, although it's not far from my buying target.
Under Cornell, Target went all in on DEI, most infamously in its Pride celebrations, a corporate marketing and sales effort that targeted the LBGTQ+ community.
The country's seventh largest retailer has been the bullseye for grassroots consumer boycotts, but the real cause of its woes is in the c-suite.
Target Corporation NYSE: TGT investors find themselves stuck at a crossroads. The retailer's stock, trading around $96.00 in late May 2025, has seen a decline of approximately 28% year-to-date, reflecting market concerns following the release of the first-quarter 2025 financial update.
Tesla Inc (NASDAQ:TSLA) stock has been a tale of two quarters to start the year.
I maintain my buy rating on JNJ, citing attractive valuation, improved technicals, and a raised intrinsic value target of $184 per share. JNJ's recent earnings beat expectations, with strong Medicine and MedTech growth, a 63rd consecutive dividend hike, and healthy free cash flow. Litigation headwinds are easing, and management raised revenue guidance, though they remain cautious on earnings due to tariffs and acquisitions.
Target (TGT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Target's recent earnings missed expectations, but underlying financial strength and stable margins signal resilience, despite near-term consumer headwinds. Current valuation is historically low at 10x P/E, offering an attractive entry point with a nearly 5% dividend yield for long-term investors. Brand appeal, new store openings, digital media growth, and strategic partnerships position Target for recovery and future growth.
Target Corporation's Q1 2025 results were weak, with declining sales, falling comps, and a one-time legal gain masking operational weakness. Competitive pressure from Walmart and Costco, macro headwinds, and tariffs add to Target's challenges, with no near-term catalyst for improvement. Despite an attractive valuation and 4.5% dividend yield, negative comps, weak traffic, and shrinking margins make TGT stock a potential value trap.